A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation – a socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 131 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 70 countries worldwide.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
11 June 2020

Technologies Against Coronavirus: Predictive Analytics Systems, Microchips and other Future Solutions

The COVID-19 pandemic is a serious stress test for healthcare systems. At the same time, it has led to the mobilization of hidden resources and is stimulating the creation of new drugs and solutions. What projects are under development in Russia right now? Read more in this series of posts from the Roscongress Foundation and Skolkovo Foundation.

Bio Zet Laboratory

An antibacterial solution for surface treatment that reduces the multiplication of pathogenic microflora, including various viruses. Biocidal activity is maintained when combined with various polymer matrices, which enables the product to be used, among other things, to produce food storage containers. A prototype has been developed.


When a patient is tested positive for COVID-19, one of the parameters determining the need for hospitalization is an assessment of the level of blood oxygen saturation. With the BIXXI neurointerface solution you can quickly obtain cerebral oxygenation values and more accurately determine the need for hospitalization. This reduces mortality rates and the burden on hospitals.


Aelita anaesthesia and respiratory device based on an advanced ventilation module for inhalation anaesthetics and artificial lung ventilation. The equipment is available for installation in intensive care units. It assists in the treatment of patients suffering from severe complications due to COVID-19.


The Anti-Virus Lamp is a closed recirculation device for purifying air in rooms constantly inhabited by people. It is suitable for offices. 254nm UV lamps kill viruses and harmful bacteria. The product is integrated into a built-in ceiling light fixture.


Disinfection station for biohazardous wastewater from hospitals based on the dispensing of highly effective reagents, in particular chlorine dioxide. The technology is effective against enveloped RNA viruses, and in particular the SARS-CoV coronavirus family. The company has its own production facility. Its devices are patented.


A predictive analytics system using Webiomed AI for the analysis of anonymous personalized medical data to identify risk factors and make predictions on future disease risks in patients, including pneumonia due to COVID-19 infection. An algorithm for determining the risk group of patients with coronavirus is being developed.


A mobile VR simulation kit for training medical personnel in hospitals and medical schools during a coronavirus pandemic. It includes an array of highly realistic scenarios for developing personal health and safety techniques for medical personnel, as well as disease diagnosis and the treatment of patients with COVID-19.


Care Mentor AI is an artificial intelligence system that aims to accelerate the analysis of chest x-ray and CT scans of patients with suspected viral pneumonia, which is currently primarily caused by coronavirus. The solution significantly reduces the doctor’s workload, prioritizes findings that require his or her attention, and reduces the number of medical errors.

IBM Scientific and Technical Centre

An AI-based chatbot based on the IBM Watson Assistant solution to provide the public with quick and easy to access information about COVID-19. The knowledge base contains 100 scripts and 1,495 common questions. It provides statistical information and collates feedback from users that is used to improve the chatbot. The chatbot aims to process 70% of requests in a natural language without the participation of an agent.


An Xray.Covid19 software module, enabling the automation of the search for signs of pneumonia on radiographs and symptoms characteristic of severe COVID-19. Medics can use this service to quickly identify deviations and adopt a decision on further treatment.

Third Opinion

Software for classifying patient analyses according to inflammatory reaction. It enables people without signs of viral infection to be identified out of those being tested. If there are signs of inflammation, the patient is given priority in COVID-19 testing.

Kleofas Engineering

An innovative device using electrodeless ultraviolet lamps for the highly efficient water, air and surface decontamination of the entire known spectrum of dangerous viruses and bacteria. The device runs on solar panels and storage systems and disinfects due to the highly efficient transformation of microwave radiation into ultraviolet. A prototype has been developed.


Russia’s first manufacturer of tissue microchips (TMA) for researching new drugs. These microchips incorporate a set of human tissues as opposed to an individual sample of each tissue, and this enables accurate results to be obtained on the effect of a drug in a single experiment instead of dozens. With TMA, biopharmaceutical companies will be able to test the cross-reactivity of antibodies and evaluate the safety of new drugs for SARS-COV-2 much faster.


Rapid test (test strip) for a quick (5-10 minutes) diagnosis of COVID-19. The test will be effective from 3-4 days after infection, often before the primary symptoms appear. The test strip is under development and testing is due to begin in the summer of 2020.


Cryodez-Neo environmentally friendly, antimicrobial product in powder form for cleaning and disinfecting public spaces and factories in order to combat pathogenic microorganisms and reduce the spread of the COVID-19 virus. The original formulation of the product with peracetic acid increases the speed and convenience of the development of treatment solutions.


Production lines of antiseptic formulations adapted for the manufacture of both liquid and gel products. Provides automatic dosing of agents, rapid homogenization and packaging of the finished product. The production rate is 70–100% higher than in standard systems with gate agitators. The delivery time of a fully equipped production line is 7 days.

Articles on the topic
Analytics on the topic